Johnson & Johnson vaccines are expected to be imported to India by June-July 2021 Johnson & Johnson is working closely with Biological E to facilitate the ongoing tech transfer to India, Renu Swarup, Secretary, Department of Biotechnology said

Public forecasts by its only two vaccine producers show their total monthly output of 70-80 million doses will increase only in two months or more, though the number of people eligible for vaccines will double to an estimated 800 million from May 1

In order to speed up the nationwide vaccination drive, the Centre had last week fast-tracked approval process for foreign vaccines which have been approved by the drug regulators in US, Europe, UK and Japan

Mumbai headquartered pharma and nutraceutical specialty ingredient maker VAV Lifesciences and its subsidiary VAV Lipids is going to supply highly purified 'synthetic phospholipids' required for vaccine manufacturing in US

Imports of Russia's Sputnik V vaccine are due to arrive soon and the government has also urged Pfizer, Moderna and Johnson and Johnson to sell their products to India

The Pune-headquartered company had received approval in December last year to start phase 1 and 2 trials for its COVID-19 vaccine candidate.

India is battling a massive surge in COVID-19 cases and health ministry data updated on Sunday showed that a record single-day rise of 2,61,500 coronavirus infections has taken the country's total tally to 1,47,88,109

The plan is to help establish one or more technology transfer hubs that will transfer a comprehensive technology package and provide appropriate training to interested manufacturers

The United States earlier this week paused distribution of the J&J vaccine to investigate six cases of a rare brain blood clot known as cerebral venous sinus thrombosis (CVST), accompanied by a low blood platelet count, in U.S. women under age 50

The Joint Committee on Vaccination and Immunisation (JCVI) said around 90,000 pregnant women had been vaccinated in the United States, mainly with the two American vaccines, without any safety concerns being raised

The research found that the rare blood clotting known as Cerebral Venous Thrombosis (CVT) is more common after Covid-19 than in any of the comparison groups, with 30 per cent of these cases occurring in the under 30s

The report, titled \"Managing India's second COVID-19 wave: Urgent steps\", underlines the key elements of the second COVID-19 wave. It also suggests measures that should be taken now to help mitigate the spread of infection

The United Kingdom launched its inoculation drive in December and has already offered a first shot to all over-50s, the clinically vulnerable and health workers

Rahul Gandhi tweeted, citing Mahatma Gandhi's quote: 'First they ignore you. Then they laugh at you. Then they fight you. Then you win'. He also tagged a media report, saying the Centre has fast-tracked emergency approval for foreign-produced jabs.

The vaccine maker said the six-month follow-up of its original late-stage study of the vaccine showed that vaccine efficacy remained consistent with its previous updates

Drug major Dr Reddy's Laboratories is also going to tap domestically sourced jabs as their production speeds up in India

The Johnson & Johnson pause, which regulators say they hope to resolve within days, comes on the heels of production issues at the Baltimore plant that produces the J&J vaccine

The vaccines which are listed in World Health Organization's (WHO) emergency use listing will also be granted emergency use approval in India.

Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses

India bans Remdesivir exports till COVID surge abates India has banned the export of Remdesivir injection and active pharmaceutical ingredients (API) used for making the coronavirus medication till the recent surge in COVID-19 cases subsides. India has been witnessing a surge in COVID-19 cases with the second wave of the pandemic. As of Sunday, the number of active cases stood at 11.08 lakh. This has led to a sudden spike in demand for Injection Remdesivir used in treatment of COVID patient...